See more : PT Voksel Electric Tbk (VOKS.JK) Income Statement Analysis – Financial Results
Complete financial analysis of National Health Investors, Inc. (NHI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of National Health Investors, Inc., a leading company in the REIT – Healthcare Facilities industry within the Real Estate sector.
- Schaeffler India Limited (SCHAEFFLER.NS) Income Statement Analysis – Financial Results
- Disco Corporation (DISPF) Income Statement Analysis – Financial Results
- Weatherford International plc (WFRD) Income Statement Analysis – Financial Results
- SportsTek Acquisition Corp. (SPTKU) Income Statement Analysis – Financial Results
- LXRandCo, Inc. (LXR.TO) Income Statement Analysis – Financial Results
National Health Investors, Inc. (NHI)
About National Health Investors, Inc.
Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 319.84M | 278.19M | 298.72M | 332.81M | 318.08M | 294.61M | 278.66M | 248.50M | 228.99M | 177.51M | 117.83M | 96.95M | 82.70M | 78.40M | 64.22M | 63.01M | 62.31M | 150.72M | 157.38M | 155.56M | 162.49M | 171.78M | 139.17M | 147.51M | 131.16M | 102.29M | 110.18M | 99.43M | 87.90M | 71.40M | 49.50M | 39.40M | 7.90M |
Cost of Revenue | 11.51M | 9.79M | 11.64M | 9.65M | 5.80M | 1.17M | 960.00K | 1.01M | 985.00K | 620.00K | 616.00K | 771.00K | 0.00 | 2.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 308.32M | 268.41M | 287.08M | 323.16M | 312.28M | 293.45M | 277.70M | 247.49M | 228.00M | 176.89M | 117.21M | 96.18M | 82.70M | 76.39M | 64.22M | 63.01M | 62.31M | 150.72M | 157.38M | 155.56M | 162.49M | 171.78M | 139.17M | 147.51M | 131.16M | 102.29M | 110.18M | 99.43M | 87.90M | 71.40M | 49.50M | 39.40M | 7.90M |
Gross Profit Ratio | 96.40% | 96.48% | 96.10% | 97.10% | 98.18% | 99.60% | 99.66% | 99.59% | 99.57% | 99.65% | 99.48% | 99.20% | 100.00% | 97.44% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Research & Development | 0.00 | 0.23 | 0.38 | 0.57 | 0.50 | 0.52 | 0.58 | 0.65 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 19.72M | 25.32M | 19.34M | 14.56M | 13.91M | 12.86M | 12.71M | 10.20M | 10.98M | 9.32M | 10.04M | 8.57M | 8.03M | 8.85M | 7.21M | 5.18M | 5.66M | 5.34M | 4.31M | 3.49M | 3.14M | 2.43M | 3.30M | 3.46M | 3.28M | 3.89M | 3.70M | 3.69M | 3.40M | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 100.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 19.82M | 25.32M | 19.34M | 14.56M | 13.91M | 12.86M | 12.71M | 10.20M | 10.98M | 9.32M | 10.04M | 8.57M | 8.03M | 8.85M | 7.21M | 5.18M | 5.66M | 5.34M | 4.31M | 3.49M | 3.14M | 2.43M | 3.30M | 3.46M | 3.28M | 3.89M | 3.70M | 3.69M | 3.40M | 0.00 | 0.00 | 0.00 | 0.00 |
Other Expenses | 109.71M | 99.92M | 134.35M | 84.68M | 78.37M | 71.35M | 67.17M | 1.66M | 53.16M | 38.08M | 3.31M | 4.85M | 12.81M | 11.05M | 7.37M | 8.55M | 2.36M | 95.15M | 116.67M | 96.24M | 101.89M | 127.25M | 115.83M | 81.79M | 99.86M | 47.87M | 53.31M | 49.21M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 129.53M | 125.24M | 153.69M | 99.23M | 92.27M | 85.37M | 80.84M | 70.77M | 65.13M | 48.01M | 30.76M | 25.92M | 20.84M | 19.90M | 14.58M | 13.73M | 8.01M | 100.50M | 120.98M | 99.73M | 105.03M | 129.67M | 119.13M | 85.25M | 103.14M | 51.76M | 57.01M | 52.90M | -7.60M | -10.50M | -8.20M | -7.10M | -1.60M |
Cost & Expenses | 143.36M | 135.03M | 165.33M | 108.88M | 98.07M | 85.37M | 80.84M | 70.77M | 65.13M | 48.01M | 30.76M | 25.92M | 20.84M | 19.90M | 14.58M | 13.73M | 8.01M | 100.50M | 120.98M | 99.73M | 105.03M | 129.67M | 119.13M | 85.25M | 103.14M | 51.76M | 57.01M | 52.90M | -7.60M | -10.50M | -8.20M | -7.10M | -1.60M |
Interest Income | -2.65M | 44.92M | 50.81M | 52.88M | 56.30M | 0.00 | 18.00K | 0.00 | 0.00 | 0.00 | 6.74M | 1.24M | 6.49M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
Interest Expense | 55.51M | 44.92M | 50.81M | 52.88M | 56.30M | 49.06M | 43.11M | 9.23M | 3.49M | 3.85M | 1.55M | 85.00K | 308.00K | 4.63M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
Depreciation & Amortization | 69.97M | 140.03M | 165.45M | 106.65M | 99.16M | 89.79M | 79.96M | 86.12M | 53.16M | 40.69M | 20.10M | 16.58M | 11.99M | 10.99M | 8.62M | 7.94M | 11.73M | 11.81M | 12.60M | 14.45M | 15.38M | 16.38M | 14.66M | 14.17M | 11.49M | 8.96M | 8.04M | 6.83M | 6.10M | 5.30M | 5.20M | 4.70M | 1.20M |
EBITDA | 251.49M | 151.99M | 212.99M | 303.95M | 296.83M | 280.59M | 264.99M | 236.08M | 179.36M | 167.06M | 107.63M | 87.66M | 76.05M | 68.15M | 57.57M | 53.34M | 82.87M | 66.31M | 49.38M | 55.29M | 72.84M | 247.76M | 233.19M | 77.60M | 91.44M | 60.18M | 61.21M | 54.48M | 101.60M | 87.20M | 62.90M | 51.20M | 10.70M |
EBITDA Ratio | 78.63% | 54.64% | 71.30% | 91.33% | 93.32% | 95.24% | 95.09% | 95.00% | 94.00% | 93.17% | 91.23% | 90.42% | 71.48% | 82.01% | 81.52% | 80.51% | 84.55% | 32.83% | 20.37% | 37.71% | 44.83% | 31.39% | 25.71% | 52.61% | 30.69% | 58.83% | 55.55% | 54.79% | 115.59% | 122.13% | 127.07% | 129.95% | 135.44% |
Operating Income | 178.79M | 81.11M | 132.19M | 220.80M | 220.01M | 209.24M | 197.82M | 177.73M | 163.86M | 106.19M | 77.84M | 71.04M | 61.86M | 58.50M | 49.64M | 49.27M | 54.30M | 50.23M | 36.40M | 55.83M | 57.46M | 42.11M | 20.04M | 62.26M | 28.02M | 50.53M | 53.17M | 46.53M | 95.50M | 81.90M | 57.70M | 46.50M | 9.50M |
Operating Income Ratio | 55.90% | 29.16% | 44.25% | 66.34% | 69.17% | 71.02% | 70.99% | 71.52% | 71.56% | 59.82% | 66.07% | 73.27% | 74.80% | 74.62% | 77.30% | 78.20% | 87.14% | 33.32% | 23.13% | 35.89% | 35.36% | 24.51% | 14.40% | 42.21% | 21.37% | 49.40% | 48.26% | 46.80% | 108.65% | 114.71% | 116.57% | 118.02% | 120.25% |
Total Other Income/Expenses | -44.41M | -80.22M | -15.04M | -33.54M | -59.56M | -49.94M | -38.45M | -74.13M | -66.10M | -26.44M | -28.49M | 0.00 | 7.95M | -707.00K | 0.00 | 0.00 | -3.48M | 8.44M | 16.93M | -4.89M | 0.00 | -185.02M | -218.78M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income Before Tax | 134.38M | 65.50M | 111.97M | 185.31M | 160.45M | 154.33M | 159.37M | 153.47M | 149.61M | 103.05M | 79.50M | 74.66M | 81.13M | 69.42M | 64.23M | 57.51M | 67.64M | 62.95M | 53.71M | 67.52M | 0.00 | 47.19M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income Before Tax Ratio | 42.02% | 23.55% | 37.48% | 55.68% | 50.44% | 52.39% | 57.19% | 61.76% | 65.33% | 58.05% | 67.47% | 77.01% | 98.10% | 88.55% | 100.01% | 91.28% | 108.55% | 41.76% | 34.13% | 43.41% | 0.00% | 27.47% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | 0.00 | 42.44M | 49.78M | 49.94M | 56.29M | -9.17M | 46.32M | 749.00K | -707.00K | 24.67M | -17.13M | -12.53M | -19.27M | -10.92M | -14.59M | -8.24M | -42.13M | -18.83M | -17.65M | -472.00K | 13.66M | 11.83M | 21.19M | 29.70M | -24.85M | -18.42M | -22.22M | -19.52M | 45.80M | 43.00M | 33.30M | 33.20M | 7.40M |
Net Income | 135.65M | 23.06M | 62.19M | 135.37M | 104.16M | 154.33M | 159.37M | 151.54M | 148.86M | 101.61M | 106.18M | 90.73M | 81.13M | 69.42M | 64.23M | 57.51M | 96.44M | 69.23M | 54.41M | 56.38M | 43.81M | 30.79M | -63.00K | 33.72M | 53.62M | 69.65M | 75.39M | 67.16M | 49.70M | 38.90M | 24.40M | 13.30M | 2.10M |
Net Income Ratio | 42.41% | 8.29% | 20.82% | 40.67% | 32.75% | 52.39% | 57.19% | 60.98% | 65.01% | 57.24% | 90.12% | 93.58% | 98.10% | 88.55% | 100.01% | 91.28% | 154.76% | 45.93% | 34.57% | 36.24% | 26.96% | 17.92% | -0.05% | 22.86% | 40.88% | 68.08% | 68.42% | 67.55% | 56.54% | 54.48% | 49.29% | 33.76% | 26.58% |
EPS | 3.13 | 0.52 | 1.36 | 3.03 | 2.40 | 3.68 | 3.90 | 3.88 | 3.96 | 3.04 | 3.74 | 3.26 | 2.93 | 2.51 | 2.33 | 2.08 | 3.48 | 2.50 | 1.96 | 2.05 | 1.58 | 1.10 | 0.00 | 1.31 | 2.13 | 2.72 | 3.01 | 2.92 | 2.63 | 2.35 | 1.95 | 1.60 | 0.29 |
EPS Diluted | 3.13 | 0.51 | 1.36 | 3.03 | 2.38 | 3.67 | 3.87 | 3.87 | 3.95 | 3.04 | 3.74 | 3.26 | 2.92 | 2.50 | 2.32 | 2.07 | 3.47 | 2.49 | 1.96 | 2.03 | 1.57 | 1.10 | 0.00 | 1.31 | 2.13 | 2.69 | 2.92 | 2.80 | 2.49 | 2.28 | 1.95 | 1.60 | 0.29 |
Weighted Avg Shares Out | 43.39M | 44.77M | 45.71M | 44.70M | 43.42M | 41.94M | 40.89M | 39.01M | 37.60M | 33.38M | 28.36M | 27.81M | 27.72M | 27.66M | 27.59M | 27.71M | 27.70M | 27.74M | 27.70M | 27.26M | 26.73M | 26.45M | 24.47M | 24.38M | 24.37M | 24.96M | 24.42M | 21.94M | 16.39M | 13.28M | 12.51M | 7.48M | 7.24M |
Weighted Avg Shares Out (Dil) | 43.39M | 44.79M | 45.73M | 44.70M | 43.70M | 42.09M | 41.15M | 39.16M | 37.64M | 33.42M | 28.40M | 27.84M | 27.79M | 27.73M | 27.62M | 27.73M | 27.78M | 27.78M | 27.83M | 27.53M | 26.99M | 26.85M | 24.47M | 24.56M | 24.37M | 28.69M | 25.17M | 27.24M | 17.31M | 13.68M | 12.51M | 7.48M | 7.24M |
CHCT vs. NHI: Which Stock Is the Better Value Option?
2 Overpriced REITs To Avoid And 1 Better Buy
National Health Investors, Inc. (NHI) Q3 2024 Earnings Call Transcript
National Health Investors (NHI) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
National Health Investors (NHI) Q3 FFO Miss Estimates
NHI Announces Retirement of W. Andrew Adams from the Board of Directors
NHI Announces Fourth Quarter 2024 Dividend
NHI Issues Investor Update
NHI Announces Third Quarter 2024 Results
PLYM or NHI: Which Is the Better Value Stock Right Now?
Source: https://incomestatements.info
Category: Stock Reports